BRVE · ISSUER CIK 2131524
Braveheart Bio, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 11 Braveheart Bio, Inc. insiders reported $159.0M of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Forbion Growth Opportunities Fund III Cooperatief U.A. (10% Owner), with $64.8M.
↗11 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$159.0MInsider buying
$0.00Insider selling
+$159.0MNet open-market
Aug 11, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 202617:53 | Aug 7, 2026 | BRVE | 10% Owner · +3 joint | P · Buy | $18.00 | +1,100,000 | 10,232,420 | +12% | +$19.8M | -39.6% | +17.7% |
| Aug 11, 202617:53 | Aug 7, 2026 | BRVE | 10% Owner · +3 joint | C · Convert | — | +9,132,420 | 9,132,420 | New | — | ||
| Aug 11, 202617:31 | Aug 7, 2026 | BRVE | Director, 10% Owner | P · Buy | $18.00 | +1,940,000 | 273,333 | — | +$34.9M | -39.6% | +17.7% |
| Aug 11, 202617:31 | Aug 7, 2026 | BRVE | Director, 10% Owner | C · Convert | — | +9,132,420 | 10,235,159 | +828% | — | ||
| Aug 11, 202617:27 | Aug 7, 2026 | BRVE | Director, 10% Owner · +2 joint | P · Buy | $18.00 | +1,940,000 | 273,333 | — | +$34.9M | -39.6% | +17.7% |
| Aug 11, 202617:27 | Aug 7, 2026 | BRVE | Director, 10% Owner · +2 joint | C · Convert | — | +9,132,420 | 10,235,159 | +828% | — | ||
| Aug 10, 202610:03 | Aug 7, 2026 | BRVE | 10% Owner | C · Convert | — | +7,420,091 | 7,420,091 | New | — | ||
| Aug 7, 202617:25 | Aug 7, 2026 | BRVE | 10% Owner · +3 joint | P · Buy | $18.00 | +3,600,000 | 11,640,546 | +45% | +$64.8M | -39.6% | +17.7% |
| Aug 7, 202617:25 | Aug 7, 2026 | BRVE | 10% Owner · +3 joint | C · Convert | — | +17,123,287 | 9,720,546 | — | — | ||
| Aug 7, 202616:41 | Aug 7, 2026 | BRVE | Chief Financial Officer | P · Buy | $18.00 | +27,777 | 520,927 | +6% | +$500K | -39.6% | +17.7% |
| Aug 7, 202616:31 | Aug 7, 2026 | BRVE | Director | P · Buy | $18.00 | +83,333 | 609,519 | +16% | +$1.5M | -39.6% | +17.7% |
| Aug 7, 202616:31 | Aug 7, 2026 | BRVE | Director | P · Buy | $18.00 | +4,166 | 533,845 | +1% | +$75K | -39.6% | +17.7% |
| Aug 7, 202616:30 | Aug 7, 2026 | BRVE | Chief Development Officer | P · Buy | $18.00 | +1,111 | 332,161 | +0% | +$20K | -39.6% | +17.7% |
| Aug 7, 202616:30 | Aug 7, 2026 | BRVE | CEO and President, Director | P · Buy | $18.00 | +83,333 | 2,940,670 | +3% | +$1.5M | -39.6% | +17.7% |
| Aug 7, 202616:30 | Aug 7, 2026 | BRVE | Director | P · Buy | $18.00 | +55,555 | 55,555 | New | +$1000K | -39.6% | +17.7% |